ICON plc Ordinary Shares (ICLR)
Stock · NASDAQ · Health Care
$169.84as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$161.96
Industry
Biotechnology: Commercial Physical & Biological Resarch
About ICLR
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinic…
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Employees
- 40,200
- Website
- www.iconplc.com/
Fundamentals
- 1-day range
- $160.46$164.89
- Market cap
- $12.34B
- P/E (trailing)
- 183.55
- P/E (forward)
- 13.86
- EPS (trailing)
- $0.90
- Dividend yield
- —
- Beta
- 1.25
- Avg. volume
- 995.0K
52-week range
$66.57$203.91
Next earnings: October 21, 2026 · EPS estimate $2.67After Closeconfirmed
Forecasts
16 analyst ratings
Buy 67%
Hold 29%
Sell 4%
1-year price forecast
High
$220
+29.5%
Median
$186.5
+9.8%
Low
$155
-8.7%
ICON plc Ordinary Shares Competitors
Chosen by industry and closest market cap.
- ICLRICON plc Ordinary Shares$169.84▲ 0.07%Market cap $12.34BP/E 183.55$66.57$203.91
- CRLCharles River Laboratories International Inc. Common Stock$291.74▼ 1.58%Market cap $12.79BP/E —$144.26$303.31
- MEDPMedpace Holdings Inc. Common Stock$599.99▼ 1.89%Market cap $16.33BP/E 33.13$373$677.9
- ABSIAbsci Corporation Common Stock$8.72▼ 7.43%Market cap $1.29BP/E —$2.24$12.06
- INCYIncyte Corp. Common Stock$124.39▼ 2.63%Market cap $24.00BP/E 15.14$81.09$132.6
- MXCTMaxCyte Inc. Common Stock$1.22▼ 4.69%Market cap $118.91MP/E —$0.643$1.87
- ONMDOneMedNet Corp Class A Common Stock$0.5801▼ 0.84%Market cap $37.18MP/E —$0.49$4.22
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ICLR ICON plc Ordinary Shares | $12.34B | 183.55 | $169.84 | ▲ 0.07% | $66.57$203.91 |
| CRL Charles River Laboratories International Inc. Common Stock | $12.79B | — | $291.74 | ▼ 1.58% | $144.26$303.31 |
| MEDP Medpace Holdings Inc. Common Stock | $16.33B | 33.13 | $599.99 | ▼ 1.89% | $373$677.9 |
| ABSI Absci Corporation Common Stock | $1.29B | — | $8.72 | ▼ 7.43% | $2.24$12.06 |
| INCY Incyte Corp. Common Stock | $24.00B | 15.14 | $124.39 | ▼ 2.63% | $81.09$132.6 |
| MXCT MaxCyte Inc. Common Stock | $118.91M | — | $1.22 | ▼ 4.69% | $0.643$1.87 |
| ONMD OneMedNet Corp Class A Common Stock | $37.18M | — | $0.5801 | ▼ 0.84% | $0.49$4.22 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 UpdateSeekingAlpha · 8/26/2026
- Insider Selling: Linda Grais Unloads $138K Of Icon StockBenzinga · 8/13/2026
- Director Of Icon Makes $138K SaleBenzinga · 8/13/2026
- Julie ONeill Executes Sell Order: Offloads $150K In Icon StockBenzinga · 8/13/2026
- Director At Icon Sells $439K Of StockBenzinga · 8/13/2026
- Insider Decision: Martin Ronan Murphy Offloads $138K Worth Of Icon StockBenzinga · 8/13/2026
- Sell Alert: Pacelli Eugene McCague Cashes Out $138K In Icon StockBenzinga · 8/13/2026
- Clem Anne Whitaker Executes Sell Order: Offloads $138K In Icon StockBenzinga · 8/13/2026
- Citigroup Maintains Neutral on Icon, Raises Price Target to $180benzinga · 7/31/2026
Insider Activity
Insider Actions →Acquired
13.3K
Disposed
13.3K
- Ronan Martin Murphy · May 14, 2026 · Grant5.0K
- Ronan Martin Murphy · May 14, 2026 · Disposition5.0K
- John Dr Climax · May 14, 2026 · Grant5.0K
- John Dr Climax · May 14, 2026 · Disposition5.0K
- Eugene Pacelli McCague · May 14, 2026 · Grant3.3K
- Eugene Pacelli McCague · May 14, 2026 · Disposition3.3K
See the full, filterable feed with live charts on the MarketWall dashboard.